The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Pulmonary Arterial Hypertension Global Market Report 2023, the pulmonary arterial hypertension market is expected to show significant growth in the forecast period.

Key insights from the pulmonary arterial hypertension market forecast include:

1. Market Size

The global pulmonary arterial hypertension market is expected to grow from $7.05 billion in 2022 to $7.63 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The pulmonary arterial hypertension market size is expected to grow to $10.47 billion in 2027 at a CAGR of 8.2%.

2. Major Driver

The rising prevalence of pulmonary arterial hypertension (PAH) condition is fueling the pulmonary arterial hypertension market. During the projected period, the rising prevalence of PAH disorders and the associated hospitalisation of patients for treatment are expected to drive up demand for relevant medications. According to a study published by the National Organisation for Rare Disorders, Inc., new instances of PAH are projected to occur in one to two people per million in the United States each year, equating to 500-1000 new cases per year, with Europe expected to have comparable incidence rates.

View More On The Pulmonary Arterial Hypertension Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report

3. Key Trend

Technological developments are important trends that are gaining traction in the pulmonary arterial hypertension market. Companies in the pulmonary arterial hypertension drug business are concentrating on the development of novel medicines to improve and cure these conditions. For example, in April 2021, United Therapeutics Corporation, a biotechnology company based in the United States, will commercialise Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease. Tyvaso is an inhalation solution that assists patients with improving their exercise abilities, decreasing respiratory difficulties, having a low tolerance for exertion, and having a higher mortality rate.

4. Largest Region

North America was the largest region in the pulmonary arterial hypertension market in 2022.

5. Major Players

Major players in the food diagnostics market are United Therapeutics Corporation, Bayer AG, Gilead Sciences Inc., Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Acceleron Pharma Inc., Eli Lilly and Company, Actelion Pharmaceuticals US Inc., Natco Pharma Ltd., Zydus Pharmaceutical USA, and Liquidia Technologies Inc.

Request A Sample Of The Global Pulmonary Arterial Hypertension Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5954&type=smp

Key Pulmonary Arterial Hypertension Market Segments
The global pulmonary arterial hypertension market is segmented –
1) By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators
2) By Route of Administration: Oral, Intravenous/ subcutaneous, Inhalational
3) By Distribution channel: Retail, Online

The Pulmonary Arterial Hypertension Global Market Report 2023  provides an in-depth analysis on the pulmonary arterial hypertension market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the pulmonary arterial hypertension market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Ocular Hypertension Treatment Global Market Report 2023
AntiHypertensive Drugs Global Market Report 2023
Low-Density Lipoprotein Test Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model